Galectin Therapeutics Inc Annual Shareholders Meeting Transcript
Good day, and welcome to the Galectin Therapeutics Annual Meeting of Stockholders. I would now like to turn the conference over to Kevin Freeman, Vice Chairman of the Board. Please go ahead, sir.
Good morning, ladies and gentlemen, welcome. My name is Kevin Freeman and I am the Vice Chairman of the Board of Galectin Therapeutics Inc. I will act as Chair of the meeting, and Mr. Jack Callicutt, our Chief Financial Officer and Corporate Secretary, will act as secretary.
Due to the potential ongoing issues with regard to the COVID-19 pandemic, we are holding this year's annual meeting as a virtual meeting. Stockholders who require technical assistance during the meeting can call Broadridge's technical support line at the number listed on our virtual meeting website. Thank you.
I hereby call the 2022 Annual Meeting for Galectin Therapeutics Inc. to order. At this time, I would like to introduce the current members of the Board of Directors, Dr. Gilbert Amelio, Director, Member
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |